{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T08:46:10Z","timestamp":1792917970139,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.labinv.2022.100037","type":"journal-article","created":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:39:49Z","timestamp":1673311189000},"page":"100037","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Aberrant Adenosine Triphosphate Release and Impairment of P2Y2-Mediated Signaling in Sarcoglycanopathies"],"prefix":"10.1016","volume":"103","author":[{"given":"Andrea","family":"Benzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Baratto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Astigiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Sturla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Panicucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamel","family":"Mamchaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizzia","family":"Raffaghello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2034-3716","authenticated-orcid":false,"given":"Santina","family":"Bruzzone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Gazzerro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.labinv.2022.100037_bib1","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1212\/WNL.52.1.176","article-title":"The clinical spectrum of sarcoglycanopathies","volume":"52","author":"Angelini","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.labinv.2022.100037_bib2","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1093\/brain\/awaa228","article-title":"New genotype-phenotype correlations in a large European cohort of patients with sarcoglycanopathy","volume":"143","author":"Alonso-P\u00e9rez","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.labinv.2022.100037_bib3","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/ana.22251","article-title":"Sustained alpha-sarcoglycan gene expression after gene transfer in limb-girdle muscular dystrophy, type 2D","volume":"68","author":"Mendell","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.labinv.2022.100037_bib4","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003541","article-title":"Transplantation of genetically corrected human iPSC-derived progenitors in mice with limb-girdle muscular dystrophy","volume":"4","author":"Tedesco","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.labinv.2022.100037_bib5","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.145994","article-title":"Base editing repairs an SGCA mutation in human primary muscle stem cells","volume":"6","author":"Escobar","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.labinv.2022.100037_bib6","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2174\/1566523220666200218113526","article-title":"Limb-girdle muscular dystrophy and therapy: insights into cell and gene-based approaches","volume":"19","author":"Taheri","year":"2020","journal-title":"Curr Gene Ther"},{"key":"10.1016\/j.labinv.2022.100037_bib7","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1089\/hum.2019.199","article-title":"Preclinical systemic delivery of adeno-associated \u03b1-sarcoglycan gene transfer for limb-girdle muscular dystrophy","volume":"32","author":"Griffin","year":"2021","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.labinv.2022.100037_bib8","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2217\/nmt-2020-0066","article-title":"Unmet needs and evolving treatment for limb girdle muscular dystrophies","volume":"11","author":"Pozsgai","year":"2021","journal-title":"Neurodegener Dis Manag"},{"key":"10.1016\/j.labinv.2022.100037_bib9","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1093\/hmg\/ddn029","article-title":"Mannosidase I inhibition rescues the human alpha-sarcoglycan R77C recurrent mutation","volume":"17","author":"Bartoli","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.labinv.2022.100037_bib10","doi-asserted-by":"crossref","first-page":"170","DOI":"10.2353\/ajpath.2008.071146","article-title":"Inhibition of proteasome activity promotes the correct localization of disease-causing alpha-sarcoglycan mutants in HEK-293 cells constitutively expressing beta-, gamma-, and delta-sarcoglycan","volume":"173","author":"Gastaldello","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.labinv.2022.100037_bib11","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1093\/hmg\/ddu088","article-title":"Unveiling the degradative route of theV247M \u03b1-sarcoglycan mutant responsible for LGMD-2D","volume":"23","author":"Bianchini","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.labinv.2022.100037_bib12","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/hmg\/ddab260","article-title":"CFTR corrector C17 is effective in muscular dystrophy, in\u00a0vivo proof of concept in LGMDR3","volume":"31","author":"Scano","year":"2022","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.labinv.2022.100037_bib13","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1017\/S1462399409001203","article-title":"Sarcoglycanopathies: molecular pathogenesis and therapeutic prospects","volume":"11","author":"Sandon\u00e0","year":"2009","journal-title":"Expert Rev Mol Med"},{"key":"10.1016\/j.labinv.2022.100037_bib14","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.it.2007.08.004","article-title":"Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox","volume":"28","author":"Rubartelli","year":"2007","journal-title":"Trends Immunol"},{"key":"10.1016\/j.labinv.2022.100037_bib15","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1089\/ars.2015.6383","article-title":"Therapeutic opportunities in damage-associated molecular pattern-driven metabolic diseases","volume":"23","author":"Garcia-Martinez","year":"2015","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.labinv.2022.100037_bib16","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/nature13085","article-title":"Nucleotide signalling during inflammation","volume":"509","author":"Idzko","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.labinv.2022.100037_bib17","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3389\/fphar.2017.00661","article-title":"Purinergic signalling: therapeutic developments","volume":"8","author":"Burnstock","year":"2017","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.labinv.2022.100037_bib18","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.2353\/ajpath.2010.090058","article-title":"Inflammasome up-regulation and activation in dysferlin-deficient skeletal muscle","volume":"176","author":"Rawat","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.labinv.2022.100037_bib19","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.nbd.2003.10.014","article-title":"Enhanced expression of the P2X4 receptor in Duchenne muscular dystrophy correlates with macrophage invasion","volume":"15","author":"Yeung","year":"2004","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.labinv.2022.100037_bib20","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.nmd.2004.11.008","article-title":"Localized expression of specific P2X receptors in dystrophin deficient DMD and mdx muscle","volume":"15","author":"Jiang","year":"2005","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.labinv.2022.100037_bib21","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1096\/fj.05-4022com","article-title":"Increased susceptibility to ATP via alteration of P2X receptor function in dystrophic mdx mouse muscle cells","volume":"20","author":"Yeung","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.labinv.2022.100037_bib22","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.bbadis.2019.01.002","article-title":"Dystrophic mdx mouse myoblasts exhibit elevated ATP\/UTP-evoked metabotropic purinergic responses and alterations in calcium signalling","volume":"1865","author":"R\u00f3g","year":"2019","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.labinv.2022.100037_bib23","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1016\/j.ajpath.2015.08.010","article-title":"Enhancement of muscle T regulatory cells and improvement of muscular dystrophic process in mdx mice by blockade of extracellular ATP\/P2X axis","volume":"185","author":"Gazzerro","year":"2015","journal-title":"Am J Pathol"},{"key":"10.1016\/j.labinv.2022.100037_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001888","article-title":"P2RX7 purinoceptor: a therapeutic target for ameliorating the symptoms of Duchenne muscular dystrophy","volume":"12","author":"Sinadinos","year":"2015","journal-title":"PLoS Med"},{"key":"10.1016\/j.labinv.2022.100037_bib25","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3390\/ph15010089","article-title":"P2X7 receptor antagonist reduces fibrosis and inflammation in a mouse model of alpha-sarcoglycan muscular dystrophy","volume":"15","author":"Raffaghello","year":"2012","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.labinv.2022.100037_bib26","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ajpath.2018.10.008","article-title":"The danger signal extracellular ATP is involved in the immunomediated damage of \u03b1-sarcoglycan-deficient muscular dystrophy","volume":"189","author":"Gazzerro","year":"2019","journal-title":"Am J Pathol"},{"key":"10.1016\/j.labinv.2022.100037_bib27","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/2044-5040-1-34","article-title":"Immortalized pathological human myoblasts: towards a universal tool for the study of neuromuscular disorders","volume":"1","author":"Mamchaoui","year":"2011","journal-title":"Skelet Muscle"},{"key":"10.1016\/j.labinv.2022.100037_bib28","doi-asserted-by":"crossref","first-page":"25938","DOI":"10.1074\/jbc.M113.470435","article-title":"CD73 protein as a source of extracellular precursors for sustained NAD+ biosynthesis in FK866-treated tumor cells","volume":"288","author":"Grozio","year":"2013","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.labinv.2022.100037_bib29","doi-asserted-by":"crossref","first-page":"21067","DOI":"10.1074\/jbc.M111.324269","article-title":"NAD+ levels control Ca2+ store replenishment and mitogen-induced increase of cytosolic Ca2+ by cyclic ADP-ribose-dependent TRPM2 channel gating in human T lymphocytes","volume":"287","author":"Magnone","year":"2012","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.labinv.2022.100037_bib30","doi-asserted-by":"crossref","first-page":"28045","DOI":"10.1074\/jbc.M109.035329","article-title":"LANCL2 is necessary for abscisic acid binding and signaling in human granulocytes and in rat insulinoma cells","volume":"284","author":"Sturla","year":"2009","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.labinv.2022.100037_bib31","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394Ct method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.labinv.2022.100037_bib32","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1042\/BJ20051302","article-title":"Extracellular NAD+ regulates intracellular calcium levels and induces activation of human granulocytes","volume":"393","author":"Bruzzone","year":"2006","journal-title":"Biochem J"},{"key":"10.1016\/j.labinv.2022.100037_bib33","doi-asserted-by":"crossref","first-page":"540370","DOI":"10.1155\/2013\/540370","article-title":"Cytokines and chemokines as regulators of skeletal muscle inflammation: presenting the case of Duchenne muscular dystrophy","volume":"2013","author":"De Paepe","year":"2013","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.labinv.2022.100037_bib34","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/s41584-020-0455-8","article-title":"Cell death in chronic inflammation: breaking the cycle to treat rheumatic disease","volume":"16","author":"Anderton","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.labinv.2022.100037_bib35","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.imlet.2018.11.006","article-title":"Extracellular nucleotides and nucleosides as signalling molecules","volume":"205","author":"Giuliani","year":"2019","journal-title":"Immunol Lett"},{"key":"10.1016\/j.labinv.2022.100037_bib36","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1152\/physrev.00015.2002","article-title":"Molecular physiology of P2X receptors","volume":"82","author":"North","year":"2002","journal-title":"Physiol Rev"},{"key":"10.1016\/j.labinv.2022.100037_bib37","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/wmts.62","article-title":"Coupling of P2Y receptors to G proteins and other signaling pathways","volume":"1","author":"Erb","year":"2012","journal-title":"Wiley Interdiscip Rev Membr Transp Signal"},{"key":"10.1016\/j.labinv.2022.100037_bib38","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1111\/jgh.13672","article-title":"Adenosine triphosphate induces P2Y2 activation and interleukin-8 release in human esophageal epithelial cells","volume":"32","author":"Wu","year":"2017","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.labinv.2022.100037_bib39","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0022-510X(99)00102-1","article-title":"Regeneration in sarcoglycanopathies: expression studies of sarcoglycans and other muscle proteins","volume":"165","author":"Fanin","year":"1999","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.labinv.2022.100037_bib40","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/B978-0-08-045031-5.00003-7","article-title":"Sarcoglycanopathies","volume":"101","author":"Kirschner","year":"2011","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.labinv.2022.100037_bib41","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1016\/S0140-6736(19)32910-1","article-title":"Muscular dystrophies","volume":"394","author":"Mercuri","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.labinv.2022.100037_bib42","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa7322","article-title":"Immune-mediated pathology in Duchenne muscular dystrophy","volume":"7","author":"Rosenberg","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.labinv.2022.100037_bib43","doi-asserted-by":"crossref","first-page":"310","DOI":"10.5414\/NP301393","article-title":"Muscle inflammatory pattern in alpha- and gamma-sarcoglycanopathies","volume":"40","author":"Panicucci","year":"2021","journal-title":"Clin Neuropathol"},{"key":"10.1016\/j.labinv.2022.100037_bib44","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.coph.2019.02.003","article-title":"P2X7 purinoceptor as a therapeutic target in muscular dystrophies","volume":"47","author":"G\u00f3recki","year":"2019","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.labinv.2022.100037_bib45","article-title":"The immune system in Duchenne muscular dystrophy: Friend or foe","volume":"3","author":"Villalta","year":"2015","journal-title":"Rare Dis"},{"key":"10.1016\/j.labinv.2022.100037_bib46","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40478-018-0530-4","article-title":"Zidovudine ameliorates pathology in the mouse model of Duchenne muscular dystrophy via P2RX7 purinoceptor antagonism","volume":"6","author":"Al-Khalidi","year":"2018","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.labinv.2022.100037_bib47","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1124\/mol.104.003269","article-title":"P2Y2 receptor activation regulates the expression of acetylcholinesterase and acetylcholine receptor genes at vertebrate neuromuscular junctions","volume":"66","author":"Tung","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.labinv.2022.100037_bib48","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/mus.25199","article-title":"P2Y2 purinergic receptors are highly expressed in cardiac and diaphragm muscles of mdx mice, and their expression is decreased by suramin","volume":"55","author":"De Oliveira Moreira","year":"2017","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.labinv.2022.100037_bib49","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1186\/s12891-021-04569-y","article-title":"P2Y2 promotes fibroblasts activation and skeletal muscle fibrosis through AKT, ERK, and PKC. BMC","volume":"22","author":"Chen","year":"2021","journal-title":"Musculoskelet Disord"},{"key":"10.1016\/j.labinv.2022.100037_bib50","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.omtn.2022.02.016","article-title":"mRNA-mediated delivery of gene editing tools to human primary muscle stem cells","volume":"28","author":"Stadelmann","year":"2022","journal-title":"Mol Ther Nucleic Acids"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722026277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722026277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T19:58:04Z","timestamp":1758398284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683722026277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0023683722026277"],"URL":"https:\/\/doi.org\/10.1016\/j.labinv.2022.100037","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aberrant Adenosine Triphosphate Release and Impairment of P2Y2-Mediated Signaling in Sarcoglycanopathies","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.labinv.2022.100037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 United States & Canadian Academy of Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100037"}}